» Articles » PMID: 26252185

Hypothesis: Neuroendocrine Mechanisms (Hypothalamus-Growth Hormone-STAT5 Axis) Contribute to Sex Bias in Pulmonary Hypertension

Overview
Journal Mol Med
Publisher Biomed Central
Date 2015 Aug 8
PMID 26252185
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary hypertension (PH) is a disease with high morbidity and mortality. The prevalence of idiopathic pulmonary arterial hypertension (IPAH) and hereditary pulmonary arterial hypertension (HPAH) is approximately two- to four-fold higher in women than in men. Paradoxically, there is an opposite male bias in typical rodent models of PH (chronic hypoxia or monocrotaline); in these models, administration of estrogenic compounds (for example, estradiol-17β [E2]) is protective. Further complexities are observed in humans ingesting anorexigens (female bias) and in rodent models, such as after hypoxia plus SU5416/Sugen (little sex bias) or involving serotonin transporter overexpression or dexfenfluramine administration (female bias). These complexities in sex bias in PH remain incompletely understood. We recently discovered that conditional deletion of signal transducer and activator of transcription 5a/b () in vascular smooth muscle cells abrogated the male bias in PH in hypoxic mice and that late-stage obliterative lesions in patients of both sexes with IPAH and HPAH showed reduced STAT5a/b, reduced Tyr-P-STAT5 and reduced B-cell lymphoma 6 protein (BCL6). In trying to understand the significance of these observations, we realized that there existed a well-characterized E2-sensitive central neuroendocrine mechanism of sex bias, studied over the last 40 years, that, at its peripheral end, culminated in species-specific male ("pulsatile") versus female ("more continuous") temporal patterns of circulating growth hormone (GH) levels leading to male versus female patterned activation of STAT5a/b in peripheral tissues and thus sex-biased expression of hundreds of genes. In this report, we consider the contribution of this neuroendocrine mechanism (hypothalamus-GH-STAT5) in the generation of sex bias in different PH situations.

Citing Articles

Branched-chain α-ketoacids aerobically activate HIF1α signalling in vascular cells.

Xiao W, Shrimali N, Vigder N, Oldham W, Clish C, He H Nat Metab. 2024; 6(11):2138-2156.

PMID: 39472756 PMC: 11786732. DOI: 10.1038/s42255-024-01150-4.


Branched chain α-ketoacids aerobically activate HIF1α signaling in vascular cells.

Xiao W, Shrimali N, Oldham W, Clish C, He H, Wong S bioRxiv. 2024; .

PMID: 38853866 PMC: 11160772. DOI: 10.1101/2024.05.29.595538.


The genetic architecture of the human hypothalamus and its involvement in neuropsychiatric behaviours and disorders.

Chen S, You J, Zhang W, Wu B, Ge Y, Xiang S Nat Hum Behav. 2024; 8(4):779-793.

PMID: 38182882 DOI: 10.1038/s41562-023-01792-6.


Expression of Sex Hormone Receptor and Immune Response Genes in Peripheral Blood Mononuclear Cells During the Menstrual Cycle.

Brundin P, Landgren B, Fjallstrom P, Shamekh M, Gustafsson J, Johansson A Front Endocrinol (Lausanne). 2021; 12:721813.

PMID: 34630328 PMC: 8493253. DOI: 10.3389/fendo.2021.721813.


The Third Man: DNA sensing as espionage in pulmonary vascular health and disease.

Bryant A, Pham A, Gogoi H, Mitchell C, Pais F, Jin L Pulm Circ. 2021; 11(1):2045894021996574.

PMID: 33738095 PMC: 7934053. DOI: 10.1177/2045894021996574.


References
1.
FRANTZ A, Rabkin M . Effects of estrogen and sex difference on secretion of human growth hormone. J Clin Endocrinol Metab. 1965; 25(11):1470-80. DOI: 10.1210/jcem-25-11-1470. View

2.
Holloway M, Cui Y, Laz E, Hosui A, Hennighausen L, Waxman D . Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus. Endocrinology. 2007; 148(5):1977-86. PMC: 3282149. DOI: 10.1210/en.2006-1419. View

3.
Nebigil C, Choi D, Dierich A, Hickel P, Le Meur M, Messaddeq N . Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci U S A. 2000; 97(17):9508-13. PMC: 16895. DOI: 10.1073/pnas.97.17.9508. View

4.
Mezrich J, Nguyen L, Kennedy G, Nukaya M, Fechner J, Zhang X . SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation. PLoS One. 2012; 7(9):e44547. PMC: 3435281. DOI: 10.1371/journal.pone.0044547. View

5.
Voigt J, Fink H . Serotonin controlling feeding and satiety. Behav Brain Res. 2014; 277:14-31. DOI: 10.1016/j.bbr.2014.08.065. View